Past and Present of Renal Biopsy in the Management of Patients with Glomerular Diseases

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39: 1–266.Search in Google Scholar

2. Chadban SJ, Briganti EM, Kerr PG et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol 2003; 14: 131–138.10.1097/01.ASN.0000070152.11927.4AOpen DOISearch in Google Scholar

3. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038–2047.10.1001/jama.298.17.2038Search in Google Scholar

4. Hallan SI, Coresh J, Astor BC et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006; 17: 2275–2284.1679051110.1681/ASN.2005121273Search in Google Scholar

5. Wen CP, Cheng TY, Tsai MK et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008; 371: 2173–2182.10.1016/S0140-6736(08)60952-6Search in Google Scholar

6. Levey AS, de Jong PE, Coresh J et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011; 80: 17–28.10.1038/ki.2010.483Open DOISearch in Google Scholar

7. Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol 2002; 13: 37–40.10.1681/ASN.V13suppl_1s37Search in Google Scholar

8. Collins AJ, Foley RN, Herzog C et al. United States Renal Data System, USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and EndStage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, 2011.Search in Google Scholar

9. Iversen, P. and Brun, C. Aspiration biopsy of the kidney. Am J Med. 1951; 11: 324–3301487783710.1016/0002-9343(51)90169-6Search in Google Scholar

10. Madaio MP.Renal biopsy. Kidney Int 1990; 38:529-543.223249610.1038/ki.1990.2362232496Search in Google Scholar

11. Gerth, J., Busch, M., Illner, N. et al. Are tissue samples from two different anatomical areas of the kidney necessary for adequate diagnosis?. Clin Nephrol. 2010; 74: 258–265.10.5414/CNP74258Open DOISearch in Google Scholar

12. Whittier, W.L. Complications of the percutaneous kidney biopsy. Adv Chronic Kidney Dis. 2012; 19: 179–187.10.1053/j.ackd.2012.04.00322578678Search in Google Scholar

13. Roth, R., Parikh, S., Makey, D. et al. When size matters: diagnostic value of kidney biopsy according to the gauge of the biopsy needle. Am J Nephrol. 2013; 37: 249–25410.1159/000347219Search in Google Scholar

14. Eiro, M., Katoh, T., and Watanabe, T. Risk factors for bleeding complications in percutaneous renal biopsy. Clin Exp Nephrol. 2005; 9: 40–4510.1007/s10157-004-0326-7Search in Google Scholar

15. Manno, C., Strippoli, G.F., Arnesano, L. et al. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int. 2004; 66: 1570–157710.1111/j.1523-1755.2004.00922.xOpen DOISearch in Google Scholar

16. Manno, C., Strippoli, G.F., Arnesano, L. et al. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int. 2004; 66: 1570–157710.1111/j.1523-1755.2004.00922.xOpen DOISearch in Google Scholar

17. Stratta P, Canavese C, Marengo M, Mesiano P, Besso L, Quaglia M, Bergamo D, Monga G, Mazzucco G, Ciccone G. Risk management of renal biopsy: 1387 cases over 30 years in a single centre. Eur J Clin Invest. 2007;37:954–963.10.1111/j.1365-2362.2007.01885.xSearch in Google Scholar

18. Hergesell O, Felten H, Andrassy K, Kühn K, Ritz E. Safety of ultrasound-guided percutaneous renal biopsy-retrospective analysis of 1090 consecutive cases. Nephrol Dial Transplant. 1998;13:975–977.10.1093/ndt/13.4.975Search in Google Scholar

19. Manno C, Strippoli GF, Arnesano L, Bonifati C, Campobasso N, Gesualdo L, Schena FP. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int. 2004;66:1570–1577.10.1111/j.1523-1755.2004.00922.xOpen DOISearch in Google Scholar

20. Mendelssohn DC, Cole EH. Outcomes of percutaneous kidney biopsy, including those of solitary native kidneys. Am J Kidney Dis. 1995;26:580–585.10.1016/0272-6386(95)90592-8Search in Google Scholar

21. Burstein DM, Schwartz MM, Korbet SM. Percutaneous renal biopsy with the use of real-time ultrasound. Am J Nephrol. 1991;11:195–200.10.1159/0001683031962666Open DOISearch in Google Scholar

22. Ginsburg JC, Fransman SL, Singer MA, Cohanim M, Morrin PA. Use of computerized tomography to evaluate bleeding after renal biopsy. Nephron. 1980;26:240–243.10.1159/0001819927422051Open DOISearch in Google Scholar

23. Ralls PW, Barakos JA, Kaptein EM, Friedman PE, Fouladian G, Boswell WD, Halls J, Massry SG. Renal biopsy-related hemorrhage: frequency and comparison of CT and sonography. J Comput Assist Tomogr. 1987;11:1031–1034.10.1097/00004728-198711000-00021Search in Google Scholar

24. Tøndel C, Vikse BE, Bostad L, Svarstad E. Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988-2010. Clin J Am Soc Nephrol. 2012;7:1591–1597.10.2215/CJN.02150212Search in Google Scholar

25. Eiro M, Katoh T, Watanabe T. Risk factors for bleeding complications in percutaneous renal biopsy. Clin Exp Nephrol. 2005;9:40–45.10.1007/s10157-004-0326-7Search in Google Scholar

26. Hedges SJ, Dehoney SB, Hooper JS, Amanzadeh J, Busti AJ. Evidence-based treatment recommendations for uremic bleeding. Nat Clin Pract Nephrol. 2007;3:138–153.10.1038/ncpneph0421Open DOISearch in Google Scholar

27. Corapi KM, Chen JL, Balk EM, Gordon CE. Bleeding complications of native kidney biopsy: a systematic review and meta-analysis. Am J Kidney Dis. 2012;60:62–73.10.1053/j.ajkd.2012.02.330Search in Google Scholar

28. Korbet SM, Volpini KC, Whittier WL. Percutaneous renal biopsy of native kidneys: a single-center experience of 1,055 biopsies. Am J Nephrol. 2014;39:153–162.10.1159/000358334Search in Google Scholar

29. Gupta RK, Balogun RA. Native renal biopsies: complications and glomerular yield between radiologists and nephrologists. J Nephrol. 2005; 18:553–558.Search in Google Scholar

30. Nass K, O’Neill WC. Bedside renal biopsy: ultrasound guidance by the nephrologist. Am J Kidney Dis. 1999;34:955–959.10.1016/S0272-6386(99)70058-2Search in Google Scholar

31. Bollée G, Martinez F, Moulin B, Meulders Q, Rougier JP, Baumelou A, Glotz D, Subra JF, Ulinski T, Vrigneaud L, et al. Renal biopsy practice in France: results of a nationwide study. Nephrol Dial Transplant. 2010;25:3579–3585.10.1093/ndt/gfq25420466684Search in Google Scholar

32. Cluzel P, Martinez F, Bellin MF, Michalik Y, Beaufils H, Jouanneau C, Lucidarme O, Deray G, Grenier PA. Transjugular versus percutaneous renal biopsy for the diagnosis of parenchymal disease: comparison of sampling effectiveness and complications. Radiology. 2000;215:689–693.10.1148/radiology.215.3.r00ma0768910831685Search in Google Scholar

33. Fine DM, Arepally A, Hofmann LV, Mankowitz SG, Atta MG. Diagnostic utility and safety of transjugular kidney biopsy in the obese patient. Nephrol Dial Transplant. 2004;19:1798–1802.1512888110.1093/ndt/gfh24615128881Search in Google Scholar

34. Cluzel P, Martinez F, Bellin MF, Michalik Y, Beaufils H, Jouanneau C, Lucidarme O, Deray G, Grenier PA. Transjugular versus percutaneous renal biopsy for the diagnosis of parenchymal disease: comparison of sampling effectiveness and complications. Radiology. 2000; 215:689–693.10.1148/radiology.215.3.r00ma0768910831685Search in Google Scholar

35. Misra S, Gyamlani G, Swaminathan S, Buehrig CK, Bjarnason H, McKusick MA, Andrews JC, Johnson CM, Fervenza FC, Leung N. Safety and diagnostic yield of transjugular renal biopsy. J Vasc Interv Radiol. 2008; 19:546–551.1837529910.1016/j.jvir.2007.12.44718375299Search in Google Scholar

36. Madairo MP.Renal biopsy.Kidney Int 1990; 38;529-543.10.1038/ki.1990.2362232496Open DOISearch in Google Scholar

37. Danovitch GM, Nissenson AR. The role of renal biopsy in determining therapy and prognosis in renal diasease. Am. J Nephrology 1982; 2:179-184.10.1159/000166641Search in Google Scholar

38. Pirani CL.Evaluation of kidney biopsy specimens:In : Tisher CC, Brenner BM,eds.Renal Pathology with Clinical and Functional Correlations.Lippincott, Philadelphia,1994;85-115.Search in Google Scholar

39. Ponticelli C, Mihatsch MJ.Renal biopsy: performance and interpretation.In: Cameron JS, Davison AM, Ritz E, eds.Oxford Texbook of Clinical Nephrology.Oxford Medical Publications, Oxfort.1992;141-155Search in Google Scholar

40. Appel GB, Kunis CL.Acute tubulointerstitial nephritis. In Cottran R, ed. Contemporary Issue in Nephrology, Vol.10, Tubular Interstitial Nephropaties,Churchill, Livingstone, New York, 1983;151-185.Search in Google Scholar

41. Hooke DH, Gee DC,Atkins RC.Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 1987;32:964-972.349568910.1038/ki.1987.933495689Search in Google Scholar